PRAXIS PRECISION MEDICINES, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 38.47 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-11
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 38.47M shares, a 2261.12% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 30.86M shares, a 1813.62% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 1.67M shares, a 6.80% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 1.63M shares.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 8.95M shares, a 485.12% increase from fiscal 2019.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 1.53M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | 38.47M shares 10-Q · filed 2021-05-11 | 34.67M shares derived: average of 2 quarters · filed 2021-05-11 | 23.67M shares derived: average of 3 quarters · filed 2021-05-11 | |
| 2020-12-31 | 30.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 16.26M shares derived: average of 2 quarters · filed 2021-03-17 | 8.95M shares 10-K · filed 2021-03-17 | |
| 2020-09-30 | 1.67M shares 10-Q · filed 2020-11-23 | 1.65M shares 10-Q · filed 2020-11-23 | ||
| 2020-03-31 | 1.63M shares 10-Q · filed 2021-05-11 | 1.62M shares derived: average of 2 quarters · filed 2021-05-11 | 1.60M shares derived: average of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | 1.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 1.59M shares derived: average of 2 quarters · filed 2021-03-17 | 1.53M shares 10-K · filed 2021-03-17 | |
| 2019-09-30 | 1.56M shares 10-Q · filed 2020-11-23 | 1.50M shares 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |